Kardium Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 300

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $104M

  • Investors
  • 9

Kardium General Information

Description

Manufacturer and developer of medical devices designed to help clients in the diagnosis and treatment of atrial fibrillation. The company's system provides detailed electrophysiological mapping, stimulation, and radio-frequency energy to heat and ablate cardiac tissue within the left atrium and manages the ablation of cardiac tissue, enabling medical practitioners to diagnose and treat cardiovascular diseases with ease.

Contact Information

Website
www.kardium.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 155 - 8518 Glenlyon Parkway
  • Burnaby, British Columbia V5J 0B6
  • Canada
+1 (604)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Therapeutic Devices
Vertical(s)
Corporate Office
  • 155 - 8518 Glenlyon Parkway
  • Burnaby, British Columbia V5J 0B6
  • Canada
+1 (604)

Kardium Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kardium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 31-May-2024 $104M Completed Generating Revenue
7. Later Stage VC 20-Apr-2021 Completed Generating Revenue
6. Later Stage VC (Series D) 24-Jan-2019 Completed Generating Revenue
5. Later Stage VC 07-Apr-2015 Completed Generating Revenue
4. Later Stage VC 02-Apr-2014 Completed Generating Revenue
3. Grant 18-Sep-2013 Completed Startup
2. Angel (individual) 03-Aug-2010 $868K $868K Completed Startup
1. University Spin-Out 01-Jan-2007 Completed Startup
To view Kardium’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kardium Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and developer of medical devices designed to help clients in the diagnosis and treatment of atrial fibrilla
Diagnostic Equipment
Burnaby, Canada
300 As of 2024

Yokneam, Israel
 

Palm Harbor, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kardium Competitors (16)

One of Kardium’s 16 competitors is Lumenis, a Private Equity-Backed company based in Yokneam, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lumenis Private Equity-Backed Yokneam, Israel
Oscor Corporate Backed or Acquired Palm Harbor, FL
Boston Scientific Corporation Marlborough, MA
Acutus Medical Formerly VC-backed Carlsbad, CA
Cynosure (Other Devices and Supplies) Private Equity-Backed Westford, MA
You’re viewing 5 of 16 competitors. Get the full list »

Kardium Patents

Kardium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240261035-A1 Systems and methods for facilitating movement efficiency of a medical device within a bodily cavity Pending 26-Jan-2023
US-20240252258-A1 Systems and methods for facilitating movement efficiency of a medical device within a bodily cavity Pending 26-Jan-2023
US-20230346468-A1 Systems and methods that facilitate tissue treatment based on proximity information Pending 28-Apr-2022
US-20250040977-A1 Systems and methods for selecting, activating, or selecting and activating transducers Pending 28-Apr-2022
US-20250032180-A1 Systems and methods that facilitate transducer selection for activation based on tissue contact information Pending 28-Apr-2022 A61B34/25
To view Kardium’s complete patent history, request access »

Kardium Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kardium Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Durable Capital Partners Hedge Fund Minority
Fidelity Management & Research Company Asset Manager Minority
Fidelity Investments Mutual Fund Minority
T. Rowe Price Group Asset Manager Minority
Conconi Growth Partners Family Office Minority
You’re viewing 5 of 9 investors. Get the full list »

Kardium FAQs

  • When was Kardium founded?

    Kardium was founded in 2007.

  • Where is Kardium headquartered?

    Kardium is headquartered in Burnaby, Canada.

  • What is the size of Kardium?

    Kardium has 300 total employees.

  • What industry is Kardium in?

    Kardium’s primary industry is Diagnostic Equipment.

  • Is Kardium a private or public company?

    Kardium is a Private company.

  • What is Kardium’s current revenue?

    The current revenue for Kardium is .

  • How much funding has Kardium raised over time?

    Kardium has raised $325M.

  • Who are Kardium’s investors?

    Durable Capital Partners, Fidelity Management & Research Company, Fidelity Investments, T. Rowe Price Group, and Conconi Growth Partners are 5 of 9 investors who have invested in Kardium.

  • Who are Kardium’s competitors?

    Lumenis, Oscor, Boston Scientific, Acutus Medical, and Cynosure (Other Devices and Supplies) are some of the 16 competitors of Kardium.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »